These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10461327)

  • 1. New approaches to understanding the etiology and treatment of total parenteral nutrition-associated cholestasis.
    Moss RL; Amii LA
    Semin Pediatr Surg; 1999 Aug; 8(3):140-7. PubMed ID: 10461327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parenteral nutrition-associated cholestasis.
    Teitelbaum DH
    Curr Opin Pediatr; 1997 Jun; 9(3):270-5. PubMed ID: 9229168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathogenesis and progress in treatment of neonatal total parenteral nutrition-associated cholestasis].
    Zhu MZ; Shan RB
    Zhonghua Er Ke Za Zhi; 2008 Jan; 46(1):35-7. PubMed ID: 18353236
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of cholecystokinin to prevent the development of parenteral nutrition-associated cholestasis.
    Teitelbaum DH; Han-Markey T; Drongowski RA; Coran AG; Bayar B; Geiger JD; Uitvlugt N; Schork MA
    JPEN J Parenter Enteral Nutr; 1997; 21(2):100-3. PubMed ID: 9084013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total parenteral nutrition-associated cholestasis in surgical neonates may be reversed by intravenous cholecystokinin: a preliminary report.
    Rintala RJ; Lindahl H; Pohjavuori M
    J Pediatr Surg; 1995 Jun; 30(6):827-30. PubMed ID: 7666317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of the administration of cholecystokinin on the cholestasis associated with total parenteral nutrition in experimental short bowel].
    García-Urkia N; Asensio AB; Cano A; Samprón N; García-Arenzana JM; Bachiller P; Aldazabal P; Eizaguirre I
    Cir Pediatr; 2007 Jul; 20(3):180-2. PubMed ID: 18018748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study.
    Spagnuolo MI; Iorio R; Vegnente A; Guarino A
    Gastroenterology; 1996 Sep; 111(3):716-9. PubMed ID: 8780577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ursodeoxycholic acid therapy for intractable total parenteral nutrition-associated cholestasis in surgical very low birth weight infants.
    Al-Hathlol K; Al-Madani A; Al-Saif S; Abulaimoun B; Al-Tawil K; El-Demerdash A
    Singapore Med J; 2006 Feb; 47(2):147-51. PubMed ID: 16435058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholestasis associated with total parenteral nutrition.
    Merritt RJ
    J Pediatr Gastroenterol Nutr; 1986 Jan; 5(1):9-22. PubMed ID: 3080580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver complications of pediatric parenteral nutrition--epidemiology.
    Kelly DA
    Nutrition; 1998 Jan; 14(1):153-7. PubMed ID: 9437702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parenteral nutrition related hepato-biliary disease in adults.
    Raman M; Allard JP
    Appl Physiol Nutr Metab; 2007 Aug; 32(4):646-54. PubMed ID: 17622278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methionine infusion reproduces liver injury of parenteral nutrition cholestasis.
    Moss RL; Haynes AL; Pastuszyn A; Glew RH
    Pediatr Res; 1999 May; 45(5 Pt 1):664-8. PubMed ID: 10231861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of liver biopsy in the evaluation of pediatric total parenteral nutrition cholestasis.
    Buonpane CL; Ares GJ; Englert EG; Helenowski I; Cohran VC; Hunter CJ
    Am J Surg; 2018 Oct; 216(4):672-677. PubMed ID: 30041734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total parenteral nutrition and cholestasis.
    Sandhu IS; Jarvis C; Everson GT
    Clin Liver Dis; 1999 Aug; 3(3):489-508, viii. PubMed ID: 11291236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperalimentation associated hepatotoxicity in the newborn.
    Goplerud JM
    Ann Clin Lab Sci; 1992; 22(2):79-84. PubMed ID: 1562168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Laboratory investigation and clinical application of S-adenosyl-L-methionine in the treatment of cholestasis after total parenteral nutrition].
    Li N; Zhang H; Wang S; Zhu W; Ren J; Li J
    Zhonghua Wai Ke Za Zhi; 2002 Jun; 40(6):407-10. PubMed ID: 12139793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Necrotizing enterocolitis and total parenteral nutrition-associated cholestasis.
    Moss RL; Das JB; Raffensperger JG
    Nutrition; 1996 May; 12(5):340-3. PubMed ID: 8875518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of factors contributing to the development of total parenteral nutrition-induced cholestasis.
    Drongowski RA; Coran AG
    JPEN J Parenter Enteral Nutr; 1989; 13(6):586-9. PubMed ID: 2515304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of cholecystokinin-octapeptide on the hepatobiliary dysfunction caused by total parenteral nutrition.
    Curran TJ; Uzoaru I; Das JB; Ansari G; Raffensperger JG
    J Pediatr Surg; 1995 Feb; 30(2):242-6; discussion 246-7. PubMed ID: 7738745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower systemic inflammation is associated with gut firmicutes dominance and reduced liver injury in a novel ambulatory model of parenteral nutrition.
    Samaddar A; van Nispen J; Armstrong A; Song E; Voigt M; Murali V; Krebs J; Manithody C; Denton C; Ericsson AC; Jain AK
    Ann Med; 2022 Dec; 54(1):1701-1713. PubMed ID: 35706376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.